Why Atria stock moves
Atria rose, moving against a market that fell slightly.
Written after the close on ·
Why today
16,413 news analyzed todayAtria rose, moving against a market that fell slightly.
No company news from that session explains the move.
Over the last five trading days, Atria rose clearly, outpacing a market that rose only slightly.
The move was an ordinary one for the stock, and trading volume was well above its usual level, about twice a normal session.
The most likely background is the sector's firm tone, as similar Consumer Defensive stocks in Helsinki rose over the same days.
Today's move of +0.50% was 0.7 times a normal day's 0.8%. OMX Helsinki 25 moved −0.52% on the same day.
Atria +0.50%OMX Helsinki 25 −0.52%Against the market
What analysts expect, and how often they have been right
Analysts’ estimates for Atria.
Atria earned more than expected in 6 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 6 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 16.06 EUR
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedEUR
Next reported quarter: expected earnings per share of 0.28 EUR (February 12). For the current fiscal year, expected earnings per share changed from 1.76 EUR three months ago to 1.78 EUR now. 2026 estimate: 1.78 EUR. 2027 estimate: 1.80 EUR.
Has the share price followed the business?
Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed +42% and earnings per share +2%.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn EUR
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn EUR
Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 453 m EURRevenue 2025: 1.8 bn EUR
What the key figures say about Atria
The figures connect what Atria earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -0.70 EUR–1.44 EUR. Peers: Zinzino 11.01 SEK, Swedencare 0.54 SEK, Humble Group -1.03 SEK. 2026 estimate: 1.78 EUR (1.73 EUR–1.83 EUR). 2027 estimate: 1.80 EUR (1.77 EUR–1.84 EUR).
What the company sold during the year.
2022–2025: 1.7 bn EUR–1.8 bn EUR. Peers: Zinzino 3.7 bn SEK, Swedencare 2.7 bn SEK, Humble Group 8.3 bn SEK. 2026 estimate: 1.9 bn EUR (1.9 bn EUR–1.9 bn EUR). 2027 estimate: 1.9 bn EUR (1.9 bn EUR–1.9 bn EUR).
The percentage of revenue left after the costs of running the business.
2022–2025: 2.5%–3.6%. Peers: Zinzino 14.6%, Swedencare 7.4%, Humble Group 4.1%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −5.1%–9.9%. Peers: Zinzino 55.5%, Swedencare 1.2%, Humble Group −9.7%.
The price investors pay for each unit of annual earnings per share. Not shown for a loss.
2022–2025: 7.7–10.6. Peers: Zinzino 10.3, Swedencare 35.7. 2026 estimate: 9.0. 2027 estimate: 8.9.
What investors pay for each unit the company sells.
2022–2025: 0.15–0.24. Peers: Zinzino 1.22, Swedencare 1.12, Humble Group 0.32. 2026 estimate: 0.24. 2027 estimate: 0.23.
Money paid to shareholders per share, summed by calendar year.
2017–2025: 0.40 EUR–0.70 EUR.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 4.5%–6.8%. Peers: Zinzino 5.3%, Swedencare 1.4%, Humble Group 0.0%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 3.20–32.36. Peers: Zinzino -1.40, Swedencare 3.43, Humble Group 3.73.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 0.58–1.00. Peers: Zinzino 4.12, Swedencare 0.42, Humble Group 0.58.
Market cap plus net debt, divided by operating earnings. This includes debt.
2022–2025: 7.9–89.8.
Cash left after investments, divided by the number of shares.
2022–2025: -2.58 EUR–2.34 EUR. Peers: Zinzino 17.79 SEK, Swedencare 1.35 SEK, Humble Group 0.59 SEK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 39.3%–43.2%.
The dividend explained
A dividend is money paid to shareholders. Atria paid 0.75 EUR per share in the twelve months through November 6, 2026.
On the ex-dividend day, April 24, 2026, Atria traded without the right to the 0.75 EUR dividend. The price went from 17.76 EUR to 16.70 EUR; including the dividend, the day's change was −1.7%. Entitlement passes from the company to shareholders on the ex-day; payment comes later.
2017: 0.46 EUR2018: 0.50 EUR2019: 0.40 EUR2020: 0.42 EUR2021: 0.50 EUR2022: 0.63 EUR2023: 0.70 EUR2024: 0.60 EUR2025: 0.69 EUR2026 so far: 0.75 EUR
What to watch next, and why
The earnings report shows how Atria's revenue and profit have changed.
- Earnings report
The earnings report shows how Atria's revenue and profit have changed.
Add to calendar
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Atria usually moved about 1.7%. On a normal day it moves 0.8%.
+2.45% Why? +3.09% +1.49% +1.47%
10,000 EUR in Atria bought on November 7, 2016 is worth 25,500 EUR today, with dividends reinvested.
The same amount in OMX Helsinki with dividends would have become 24,400 EUR.
What would 10,000 EUR in Atria be worth today? →
What would 10,000 EUR in Atria be worth today?
25,500 EUR
with dividends reinvested, bought on November 7, 2016. The same amount in OMX Helsinki with dividends would have become 24,400 EUR.
At worst it was worth 6,820 EUR (December 27, 2018).
The five biggest days of the journey
· −8.1% · the whole market fell 0.8% the same day
· +8.1% · the whole market rose 1.1% the same day
· −7.7% · the whole market rose 0.2% the same day
· −7.3% · the whole market rose 0.3% the same day
· −6.7% · the whole market rose 0.7% the same day
Earlier days
+2.69% market +0.50% Atria rose clearly over the week, more than the broader Helsinki market, which edged up slightly. Read →
Atria rose clearly over the week, more than the broader Helsinki market, which edged up slightly.
The move was an ordinary size for the company, and trading stayed around its usual level.
Company news in the window was limited: a completed property sale and an invitation to a Capital Markets Day, which are unlikely to be major drivers.
−0.13% market −1.18% Atria was roughly flat, unlike the market. Read →
Atria was roughly flat, unlike the market.
The stock rose slightly over five trading days while the OMX Helsinki 25 fell slightly.
The last session was an ordinary day for Atria, and the market fell clearly that day, so Atria held up better.
No company news explains the move.
Atria is trading well above its lowest close of the past year, though below its highest.
+1.14% market +1.62% Atria rose, moving in line with the market. Read →
Atria rose, moving in line with the market.
No company news from the last session explains the move.
Over the last five trading days it rose clearly, more than the market.
The sector's median move was also positive over the same window.
Atria's next earnings report is due in February 2027.
−0.26% market −1.16% Atria barely moved, while the Helsinki market fell clearly. Read →
Atria barely moved, while the Helsinki market fell clearly.
The stock held up better than the index that day.
No company news from the last session explains the move, which was an ordinary-sized day for Atria.
Earlier, Atria's interim report on 22 October showed sales up 4.0%, but a pork export ban after African swine fever weighed on earnings.
That news came out before the last session, so it is background rather than the cause.
−0.51% market +0.22% Atria was roughly unchanged over the week, while the OMX Helsinki 25 index was also roughly flat. Read →
Atria was roughly unchanged over the week, while the OMX Helsinki 25 index was also roughly flat.
The company's quarterly report on Thursday 22 October showed sales rising 4%, but a ban on pork exports after African swine fever was found in Finland weighed on earnings.
Trading on the last session was quiet and the shares moved less than the market, which fell clearly that day.
+0.51% market +0.35% Atria rose slightly, in line with the market. Read →
Atria rose slightly, in line with the market.
The company reported sales up 4% for the quarter, but a pork export ban weighed on earnings.
Over five days, Atria fell slightly while the market rose slightly.
Sales growth in Sweden and barbecue-season demand supported results.
The pork export ban from African swine fever, found in wild boar, hit export sales.
+0.13% market −3.27% Atria was roughly flat over the last five trading days, falling less than the broader Helsinki market, which dropped clearly. Read →
Atria was roughly flat over the last five trading days, falling less than the broader Helsinki market, which dropped clearly.
The company reported third-quarter results on 22 October: sales rose about 4%, helped by strong barbecue-season demand, while operating profit (EBIT, earnings before interest and tax) stayed flat as a pork export ban after African swine fever weighed on results.
The company also announced it will close its Jyväskylä plant and move beef slaughter to Kauhajoki to save costs.
The stock is well above its lowest close of the past year but below its highest, and trading volume has been well below normal.
+2.45% market −1.41% Atria rose sharply as its quarterly results beat expectations. Read →
Atria rose sharply as its quarterly results beat expectations.
Atria climbed while the OMX Helsinki 25 fell clearly, so the move was against the market.
Over the last five trading days Atria rose clearly while the market fell slightly.
The likely reasons are the better-than-expected quarterly result and strong barbecue-season sales in Finland and Sweden.
The pork export ban from African swine fever still weighs on its profit, and Atria estimates a EUR 7 million annual hit.
Learn more · Why do stocks go up and down?